EP6; USP37; EP8, 99% up by HPLC Hydrocortisone 50-23-7

Category:Active Pharmaceutical Ingredients > Other Active Pharmaceutical Ingredients
Product Name:EP6; USP37; EP8, 99% up by HPLC Hydrocortisone 50-23-7
CAS No.:50-23-7
Standard:USP, BP, EP, JP, In-house Standards
Price(USD):Negotiable
Company:Sinoway Industrial Co.Ltd.

Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: Xiamen, Fujian

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East

  • Monthly Production Capacity: 1000kg

    Packaging Information: 25kg/drum 1kg/bottle

  • Delivery Lead Time: 7 days after payment

    Sample Provided: yes

    Payment Terms: L/L

    Product Information

     

    Product name

    Hydrocortisone

    Molecular Formula

    C21H30O5

    Molecular Weight

    362.46

    CAS No.

    50-23-7

    Quality Standard

    99% up, medical grade

    Appearance

    White powder

     

    COA of Hydrocortisone

     

    Items

    Specifications

    Results

    Appearance

    A white or almost white, crystalline powder

    White crystalline powder

    Solubility

    Practically insoluble in water, sparingly soluble in acetone and in alcohol, slightly in methylene chloride

    Complies

    Identification

     

     

    A: IR-Spectrum 

    Meets the requirement

    Complies

    B: HPLC

    Meets the requirement

    Complies

    Specific optical rotation

    Between+162°and +168°

    +165.4°

    Loss on drying

    Not more than 1.0%

    0.09%

    Related substances

     

     

    Impurity D RRT0.2

    Not more than 0.50%

    0.23%

    Impurity H RRT0.3

    Not more than 0.15%

    N.D

    Impurity I RRT0.5

    Not more than 0.50%

    0.17%

    Impurity M RRT0.7

    Not more than 0.10%

    0.09%

    Impurity G RRT0.8

    Not more than 0.40%

    0.08%

    Impurity E RRT0.86

    Not more than 0.50%

    0.09%

    Impurity A RRT0.96

    Not more than 0.20%

    0.09%

    Impurity B RRT1.1

    Not more than 0.20%

    N. D

    Impurity F RRT1.4

    Not more than 0.30%

    0.06%

    Impurity C RRT1.5

    Not more than 0.50%

    0.08%

    Impurity N RRT1.7

    Not more than 0.15%

    N.D

    Any unspecified impurity

    Not more than 0.10%

    Complies

    Sum of impurities

    Not more than 2.0%

    1.01%

    Assay

    Between 97.0% and 103.0%

    100.7%

    Residual solvents (in-house)

     

     

    Methanol

    Not more than 500ppm

    Not detect out

    Ethanol

    Not more than 2000ppm

    Not detect out

    Methylene chloride

    Not more than 600ppm

    Not detect out

    Chloroform

    Not more than 60ppm

    Not detect out

    Particle size (In-house )

    90% not more than 15micron

    Complies

    Conclusion

    The product conforms to Ph.Eur. 8.0

     

    Usage

     

    Function of Hydrocortisone

     

    1. Anti-inflammatory effect: The anti-inflammatory effect of hydrocortisone is 1.25 times that of cortisone, and it has inhibitory effect on infectious and non-infectious inflammation at pharmacological doses. Hydrocortisone can increase the tension of blood vessels, reduce congestion, and reduce the permeability of capillaries, thereby reducing exudation and edema; by inhibiting the accumulation of inflammatory cells (including macrophages and white blood cells) in the inflammation site, and inhibiting phagocytosis The function of the cell stabilizes the lysosomal membrane, prevents complement from participating in the inflammatory response and the synthesis and release of inflammatory chemical mediators (such as prostaglandins, thromboxanes, and leukotrienes), thereby alleviating redness, swelling, heat, pain and other symptoms.

    2. Immunosuppressive effects: The effects of hydrocortisone, including preventing or suppressing cell-mediated immune responses, delayed allergic reactions, reducing the number of T lymphocytes, monocytes, and eosinophils, and reducing the binding of immunoglobulins to cell surface receptors It also inhibits the synthesis and release of interleukins, thereby reducing the transformation of T lymphocytes into lymphoblasts and reducing the expansion of the primary immune response. Hydrocortisone and other glucocorticoid drugs can also reduce the passage of immune complexes through the basement membrane, and reduce the concentration of complement components and immunoglobulins; it can relieve the symptoms of many allergic diseases and inhibit the pathology caused by allergic reactions Changes, such as allergic congestion, edema, exudation, skin rash, smooth muscle spasm and cell damage, can inhibit transplant rejection of tissues and organs, and can also exert certain short-term effects on autoimmune diseases.

    3. Antitoxin effect: Hydrocortisone and other glucocorticoids can improve the body's stress ability to harmful stimuli, reduce the damage of bacterial endotoxin to the body, alleviate the symptoms of toxemia, and reduce fever caused by infectious toxemia. effect. The antipyretic mechanism may be related to its inhibition of the response of the body temperature center to pyrogens, stabilization of the lysosome membrane, and reduction of the release of endogenous pyrogens.

    4. Anti-shock effect: Hydrocortisone and other glucocorticoids have antagonistic effects on toxic shock, hypovolemic shock, and cardiogenic shock. The anti-shock effect is related to the following factors: (1) dilates the constricted blood vessels and excites the heart, strengthens the contractility of the heart; (2) inhibits the production of certain inflammatory factors, reduces the systemic inflammatory response syndrome and tissue damage, makes micro Circulating hemodynamics return to normal, improving the state of shock; (3) Stabilize the lysosome membrane and reduce the formation of myocardial inhibitors; (4) Improve the body's tolerance to bacterial endotoxins.

    5. Effects on metabolism: (1) Increase liver glycogen and increase blood sugar by promoting gluconeogenesis, slowing down glucose decomposition, reducing the use of glucose by body tissues, etc.: (2) Increasing protein decomposition Metabolism increases the excretion of serum amino acids and urine nitrogen, resulting in a negative nitrogen balance. And large doses can also inhibit protein synthesis; (3) It can increase plasma cholesterol, activate the esterases under the skin of the limbs, and promote the decomposition of subcutaneous fat, which is redistributed on the face, upper chest, back of the neck, abdomen and buttocks, forming central obesity: (4) Hydrocortisone has a certain mineralocorticoid-like effect, which can enhance the reabsorption of sodium ions and the excretion of potassium, calcium and phosphorus.

    6. Effect on blood and hematopoietic system: Hydrocortisone can stimulate the hematopoietic function of bone marrow, increase the content of red blood cells and hemoglobin, large doses may increase platelets and increase the concentration of fibrinogen, and shorten the clotting time. In addition, Hydrocortisone can reduce eosinophils and lymphocytes in the blood.

    7. Others: Hydrocortisone can reduce the pathological hyperplasia of connective tissue, improve the excitability of the central nervous system, promote gastric acid and pepsin secretion, etc.

Send your message to this supplier
  • From:
  • To:
    Sinoway Industrial Co.Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service